Skip to main content
. 2018 Oct 12;9(80):35141–35161. doi: 10.18632/oncotarget.26216

Figure 3. Effect of ZSTK474 on phosphorylation status of AKT in sarcoma cell lines in vitro.

Figure 3

Cells were treated without or with ZSTK474 at the indicated concentrations for 0.5, 6 and 24 h. Samples were lysed and immunoblotted to detect phosphorylated AKT (S473), total AKT, phosphorylated S6 (S235/236), total S6 and α-tubulin as described in the Materials and Methods section.